Related Experiment Video
Updated: Aug 14, 2025

04:36
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
1.2K
Association between prediabetes/hyperglycemia and retinal diseases: A meta-analysis
Ting Wang1, Longhao Kuang1, Xue Yao1
1Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, Shenzhen, China.
European Journal of Ophthalmology
|January 17, 2023
Summary
Prediabetes and hyperglycemia increase the risk of retinal diseases, particularly macular conditions. However, this meta-analysis found no significant link to diabetic retinopathy-like conditions.
Area of Science:
- Ophthalmology
- Endocrinology
- Public Health
Background:
- Prediabetes and hyperglycemia are increasingly prevalent global health concerns.
- The impact of prediabetes/hyperglycemia on the development of various retinal diseases requires further elucidation.
Approach:
- A systematic meta-analysis was conducted using data from PubMed and EMBASE.
- Included studies were case-control or prospective cohort studies published between 2004 and 2019.
- Quality assessment and meta-analysis were performed using RevMan 5.3 software.
Key Points:
- Meta-analysis of 18 articles revealed a significantly higher incidence of retinal diseases in individuals with prediabetes/hyperglycemia compared to controls.
- Prediabetic patients showed a significantly increased incidence of macular diseases.
- No significant difference in DR-like retinopathy was observed between prediabetic and control groups.
- Hyperglycemia in neonates was linked to an elevated risk of retinopathy of prematurity (ROP).
Conclusions:
- Prediabetes/hyperglycemia is associated with an increased risk of retinal diseases, especially macular diseases.
- Screening for retinal conditions, including macular diseases, is recommended for individuals with prediabetes.
- Further research is necessary to fully understand the relationship between prediabetes/hyperglycemia and specific types of retinopathy.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
634
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
634
Pathophysiology of Diabetes
1.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes Mellitus: Overview and Type I Subtype
2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Diabetes: Management and Pharmacotherapy
327
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
327

